The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to a placebo after four ...

Did you know people with diabetes are twice as likely to develop heart disease compared to those without diabetes?

The rate of maternal mortality related to cardiovascular ... this is happening is because heart disease and hypertension are becoming more and more prevalent, as are the conditions that are connected ...

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of ...

One study found that Black women were 3 times more likely to die of maternal deaths due to cardiovascular disease than White ...

Wegovy was also associated with a lower risk of hospitalization for heart failure, cardiovascular-related death, and ...

In the SOUL trial, Rybelsus produced a 14% risk reduction of major adverse cardiovascular events in patients with type 2 ...

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral ...

Recent study shows oral semaglutide reduces cardiovascular risk in type 2 diabetes patients, enhancing diabetes and heart ...

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...